Jeffrey Friedland is an investor, author, business executive and a thought leader in the global cannabis industry. Mr. Friedland’s latest book, Marijuana: The World’s Most Misunderstood Plant was published in late 2015.
He is CEO of Friedland Capital, which was formed in 1982. Over the decades the company’s business has evolved from merchant banking with a focus on emerging market, to today, where Friedland Capital focuses on investments in the global cannabis industry. He is CEO of publicly-held INTIVA BioPharma Inc. (NTVA), which is developing cannabinoid-based drugs under U.S. Food and Drug Administration (FDA) protocols, and CEO of the majority shareholder of Canada-based INTIVA Inc. He is also a board member of Israel-based CannRX, a company focused on cannabis-based pharmaceutical development.
Mr.Friedland has been the chief executive officer and a director of a NASDAQ listed financial services company, a director of a New York Stock Exchange-listed company, and the chairman of the supervisory board of a Hong Kong-based company with a stock market listing on the Frankfurt Stock Exchange.
Mr. Friedland is featured in two weekly online television shows, Cannabis Insider TV (www.cannabisinsider.tv) and Marijuana Stocks of the Week.
Mr. Friedland has been featured or quoted in numerous publications including the Wall Street Journal, Reuters, the New York Times, Bloomberg Television, USA Today, Verslo Zinios (Lithuania), Vercernji (Croatia), International Business Times, the South China Morning Post, the Guam Daily Post, the Forward, the Jewish Week, Quartz, the Jakarta Globe, Israel Daily Television, BreitBart, NBC.com and Forbes.
Mr. Friedland has been a frequent speaker at conferences and events throughout North America, Europe and Asia, including speeches to individual, institutional investors, and cannabis industry entrepreneurs and business owners on the cannabis industry.